ME2 and hepatocellular carcinoma: The clinical connection between the tumor and surrounding normal tissues of 73 HCC patients revealed that PRMT1 was strongly expressed in HCC and strongly linked with both ME2 methylation and poor clinical prognosis [51], which is consistent with our results.